(` cr) Note 29.4 (B) Transactions with subsidiary companies 2024-25 2023-24 4. Loan given 4.00 67.00 Atul Bioscience Ltd - 32.50 Atul Finserv Ltd - 25.00 Atul Products Ltd - 9.50 Atul Rajasthan Date Palms Ltd 4.00 - 5. Sale of fixed assets (including CWIP) 1.14 1.37 Amal Ltd - 0.32 Atul Bioscience Ltd 0.24 0.38 Atul Products Ltd 0.90 0.50 Atul Europe Ltd - 0.17 6. Purchase of fixed assets (including CWIP) 1.52 - Atul Bioscience Ltd 0.00 - Atul Products Ltd 1.52 - 7. Dividend income 16.32 12.66 Atul Bio Space Ltd 1.93 - Atul Brasil Quimicos Ltda 1.20 - Atul Middle East FZ-LLC 2.12 - Atul Europe Ltd 5.47 4.35 Atul USA Inc 2.99 8.31 Atul Finserv Ltd 2.61 - 8. Investment in 9% cumulative redeemable preference shares - 94.50 Atul Products Ltd - 94.50 9. Corporate guarantee commission received 0.76 0.55 Atul Products Ltd 0.76 0.55 10. Investment in 9.5% non-cumulative redeemable preference shares* 14.50 826.72 Atul Products Ltd 14.50 826.72 *Including conversion of loan and cumulative redeemable preference shares ₹ 764.72 cr into non-cumulative redeemable preference shares during the year 2023-24. (` cr) Note 29.4 (C) Transactions with joint venture company 2024-25 2023-24 a) Sales and income 1. Sale of goods 4.21 6.03 2. Service charges received 5.60 4.20 3. Lease rent received 0.61 0.70 4. Brand usage charges 0.03 0.28 b) Purchases and expenses Purchase of goods 0.29 0.96 c) Other transactions 1. Dividends received from equity investment measured at cost 8.76 2.92 2. Reimbursements received 0.72 0.69 3. Purchase of fixed assets - 0.44 4. Sale of fixed assets 0.11 - All above transactions are with Rudolf Atul Chemicals Ltd. Note 29.4 Related party disclosures (continued) 198 198 Integrated Annual Report 2024-25
RkJQdWJsaXNoZXIy MjA2MDI2